Investing.com UK - Financial Markets Worldwide
⌛ Did you miss ProPicks’ 13% gains in May? Subscribe now & catch June’s top AI-picked stocks early.Unlock Stocks

PagerDuty, John Wiley & Sons, Ventyx Biosciences And Other Big Stocks Moving Lower On Tuesday

Published 10/10/2023, 16:37
Updated 10/10/2023, 17:40
© Reuters. PagerDuty, John Wiley & Sons, Ventyx Biosciences And Other Big Stocks Moving Lower On Tuesday
K
-
WLY
-
GRPN
-
PD
-

Benzinga - by Lisa Levin, Benzinga Editor.

U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Tuesday. Here are some big stocks recording losses in today’s session.

  • Akero Therapeutics, Inc. (NASDAQ: AKRO) shares dipped 63.9% to $17.52 after the company reported a 36-week analysis of its Phase 2b SYMMETRY study evaluating the efficacy and safety of its lead product candidate, efruxifermin.
  • 89bio, Inc. (NASDAQ: ETNB) tumbled 37.7% to $9.68.
  • Ventyx Biosciences, Inc. (NASDAQ: VTYX) fell 22.1% to $23.38 after the company announced results from the Phase 2 trial of VTX002 in patients with moderate-to-severely active ulcerative colitis.
  • John Wiley & Sons, Inc. (NYSE: WLY) shares dipped 10.4% to $31.02. Wiley reported the departure of Brian Napack as President and CEO, and the appointment of Matthew Kissner as Interim CEO, effective immediately.
  • Groupon, Inc. (NASDAQ: GRPN) declined 9% to $13.83.
  • Uranium Royalty Corp. (NASDAQ: UROY) fell 7.1% to $2.91.
  • WK Kellogg Co (NYSE: KLG) fell 6.6% to $10.69.
  • Neumora Therapeutics, Inc. (NASDAQ: NMRA) declined 6% to $11.23. Neumora reported the appointment of Robert Lenz, M.D., Ph.D., as executive vice president, head of research and development.
  • SunCar Technology Group Inc. (NASDAQ: SDA) fell 5.7% to $9.56.
  • Genelux Corporation (NASDAQ: GNLX) fell 5.7% to $22.43.
  • PagerDuty, Inc. (NYSE: PD) shares fell 3.7% to $21.03 after the company announced a proposed private placement of $350 million of convertible senior notes.
Now Read This: US Stocks Gain; PepsiCo Posts Upbeat Earnings

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Loading next article…
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.